Abattis Bioceuticals (Abattis Bioceuticals) Capex-to-Revenue : 22.25 (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Abattis Bioceuticals's Capital Expenditure for the three months ended in Sep. 2019 was $-3.80 Mil. Its Revenue for the three months ended in Sep. 2019 was $0.17 Mil.

Hence, Abattis Bioceuticals's Capex-to-Revenue for the three months ended in Sep. 2019 was 22.25.

Abattis Bioceuticals Capex-to-Revenue Historical Data

The historical data trend for Abattis Bioceuticals's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Capex-to-Revenue Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Capex-to-Revenue

Get a 7-Day Free Trial

0.42

30.00

14.16

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Capex-to-Revenue	Get a 7-Day Free Trial															10.00	4.00	13.00	0.02	22.25

Competitive Comparison of Abattis Bioceuticals's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Capex-to-Revenue falls into.

Abattis Bioceuticals Capex-to-Revenue Calculation

Abattis Bioceuticals's Capex-to-Revenue for the fiscal year that ended in Sep. 2019 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-3.822)	/	0.27
	=	14.16

Abattis Bioceuticals's Capex-to-Revenue for the quarter that ended in Sep. 2019 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-3.804)	/	0.171
	=	22.25

Abattis Bioceuticals (OTCPK:ATTBF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Abattis Bioceuticals Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.